BIO-TECHNE CORP's ticker is TECH and the CUSIP is 09073M104. A total of 431 filers reported holding BIO-TECHNE CORP in Q4 2020. The put-call ratio across all filers is 1.11 and the average weighting 0.2%.
About BIO-TECHNE CORP
Bio-Techne Corp is a leading provider of innovative life science research tools and diagnostic solutions. The company is headquartered in Minneapolis, Minnesota, and has operations in over 50 countries worldwide. Bio-Techne's products and services are used by researchers and clinicians in a wide range of fields, including cancer research, stem cell research, and immunology.
Bio-Techne's success is due in large part to its commitment to innovation and customer service. The company invests heavily in research and development, and has a team of over 1,000 scientists working to develop new products and technologies. Bio-Techne also has a strong focus on customer service, with a dedicated team of technical support specialists available to assist customers with any questions or issues they may have.
In addition to its research tools and diagnostic solutions, Bio-Techne also has a growing portfolio of clinical diagnostic products. The company's Exosome Diagnostics subsidiary is a leader in the development of liquid biopsy tests for cancer diagnosis and monitoring.
Bio-Techne's leadership team is comprised of experienced executives with a track record of success in the life sciences industry. Charles Kummeth, the company's CEO, has been with Bio-Techne since 2013 and has overseen significant growth and expansion during his tenure.
Overall, Bio-Techne is a company with a strong reputation for innovation, customer service, and leadership in the life sciences industry. With a growing portfolio of products and services, the company is well-positioned for continued success in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $11,475,745 | -40.4% | 168,263 | -28.6% | 0.01% | -40.0% |
| Q2 2023 | $19,269,668 | +1.3% | 235,809 | -8.1% | 0.02% | -13.0% |
| Q1 2023 | $19,027,447 | -20.6% | 256,617 | -11.7% | 0.02% | -17.9% |
| Q4 2022 | $23,967,528 | +206.8% | 290,646 | +962.9% | 0.03% | +115.4% |
| Q3 2022 | $7,811,000 | -25.1% | 27,345 | -8.7% | 0.01% | -13.3% |
| Q2 2022 | $10,435,000 | -20.1% | 29,936 | +0.3% | 0.02% | -6.2% |
| Q1 2022 | $13,053,000 | -46.5% | 29,837 | -36.9% | 0.02% | -30.4% |
| Q4 2021 | $24,383,000 | +76.5% | 47,282 | +67.1% | 0.02% | +64.3% |
| Q3 2021 | $13,812,000 | +291.2% | 28,300 | +260.1% | 0.01% | +250.0% |
| Q2 2021 | $3,531,000 | +117.6% | 7,859 | +84.1% | 0.00% | +100.0% |
| Q1 2021 | $1,623,000 | -62.8% | 4,268 | -69.0% | 0.00% | -66.7% |
| Q4 2020 | $4,366,000 | +872.4% | 13,759 | +661.4% | 0.01% | +500.0% |
| Q3 2020 | $449,000 | -33.4% | 1,807 | -29.2% | 0.00% | 0.0% |
| Q2 2020 | $674,000 | -36.0% | 2,553 | -53.3% | 0.00% | -50.0% |
| Q1 2020 | $1,053,000 | +62.8% | 5,466 | +85.6% | 0.00% | +100.0% |
| Q4 2019 | $647,000 | +164.1% | 2,945 | +135.4% | 0.00% | – |
| Q3 2019 | $245,000 | -54.5% | 1,251 | -53.9% | 0.00% | -100.0% |
| Q1 2019 | $539,000 | -95.2% | 2,714 | -96.5% | 0.00% | -95.2% |
| Q4 2018 | $11,204,000 | +2229.3% | 77,416 | +3180.3% | 0.02% | +2000.0% |
| Q3 2018 | $481,000 | +130.1% | 2,360 | +70.6% | 0.00% | – |
| Q1 2018 | $209,000 | -35.7% | 1,383 | -58.1% | 0.00% | -100.0% |
| Q2 2015 | $325,000 | -6.1% | 3,297 | -4.5% | 0.00% | 0.0% |
| Q1 2015 | $346,000 | +42.4% | 3,453 | +31.5% | 0.00% | 0.0% |
| Q4 2014 | $243,000 | – | 2,625 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Broadcrest Asset Management, LLC | 300,000 | $24,489,000 | 21.05% |
| Montanaro Asset Management Ltd | 388,800 | $31,737,744 | 5.02% |
| Sandhill Capital Partners LLC | 502,447 | $41,014,775 | 3.74% |
| Brown Capital Management | 3,160,892 | $258,023,614 | 3.66% |
| DF DENT & CO INC | 3,275,617 | $267,388,640 | 3.62% |
| Ownership Capital B.V. | 2,282,104 | $186,288,150 | 3.26% |
| Jackson Square Partners, LLC | 1,361,789 | $111,162,836 | 3.24% |
| STONE RUN CAPITAL, LLC | 88,135 | $7,194,460 | 3.20% |
| Pembroke Management, LTD | 339,591 | $27,720,813 | 2.99% |
| Summit Creek Advisors LLC | 283,693 | $23,157,860 | 2.90% |